Filing Details

Accession Number:
0001062993-23-006330
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 20:04:49
Reporting Period:
2023-03-06
Accepted Time:
2023-03-08 20:04:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478320 Adaptive Biotechnologies Corp ADPT Biological Products, (No Disgnostic Substances) (2836) 270907024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780662 Kyle Piskel C/O Adaptive Biotechnologies Corporation
1165 Eastlake Avenue East
Seattle WA 98109
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-06 43,735 $0.00 91,093 No 4 A Direct
Common Stock Disposition 2023-03-06 3,300 $8.57 87,793 No 4 S Direct
Common Stock Disposition 2023-03-06 229 $8.58 87,564 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.